Multiple growth factor independence in rat mammary carcinoma cells
dc.contributor.author | Moorthy, Ramesh | en_US |
dc.contributor.author | Ethier, Stephen P. | en_US |
dc.date.accessioned | 2006-09-11T14:25:32Z | |
dc.date.available | 2006-09-11T14:25:32Z | |
dc.date.issued | 1991-05 | en_US |
dc.identifier.citation | Ethier, Stephen P.; Moorthy, Ramesh; (1991). "Multiple growth factor independence in rat mammary carcinoma cells." Breast Cancer Research and Treatment 18(2): 73-81. <http://hdl.handle.net/2027.42/44197> | en_US |
dc.identifier.issn | 0167-6806 | en_US |
dc.identifier.issn | 1573-7217 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/44197 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=1912610&dopt=citation | en_US |
dc.description.abstract | In previous studies we demonstrated that rat mammary tumor (RMT) cells that are serially transplantable consist of cells that are independent of growth factors strictly required by normal rat mammary epithelial (RME) cells for growth in serum-free culture. The present studies were designed to determine the extent of the growth factor independence of several cell lines derived from these tumors and to determine if the cells that expressed growth factor independence in vitro are also tumorigenic in vivo . Cells from a transplantable mammary carcinoma (8–12 RMT) were seeded into culture in serum-free medium in the absence of either insulin (IN), epidermal growth factor (EGF), or cholera toxin (CT), and cell populations independent of the individual factors were developed. Next, the three growth factor independent populations were tested for their ability to grow in the absence of multiple growth factors. 8–12 RMT cells did not lose proliferative potential when multiple growth factors were deleted from the medium. Indeed, 8–12 RMT cells could be serially propagated in serum-free medium supplemented solely with bovine serum albumin (BSA) and ethanolamine. Cell lines independent of single growth factors were also developed from two other transplantable tumors (1–9 RMT and 7–15 RMT). In contrast to the 8–12 RMT-derived cell lines, deletion of additional growth factors from the media of the 1–9 RMT and 7–15 RMT-derived cells resulted in dramatic losses in growth potential. These results suggest that independence of individual growth factors is mediated by different mechanisms, since cells from different tumors can stably express independence of one, two, or three or more factors. Examination of conditioned media of four different RMT cell lines indicates that independence of EGF is mediated by autocrine factors. By contrast, there is no evidence for an autocrine factor that mediates independence of insulin-like growth factors. Thus, cell lines derived from serially transplantable RMTs are independent of either single or multiple growth factors, and independence of individual growth factors appears to be mediated by separate mechanisms. | en_US |
dc.format.extent | 860249 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Kluwer Academic Publishers; Springer Science+Business Media | en_US |
dc.subject.other | Oncology | en_US |
dc.subject.other | Growth Factor Independence | en_US |
dc.subject.other | Medicine & Public Health | en_US |
dc.subject.other | Autocrine Factors | en_US |
dc.subject.other | Cholera Toxin | en_US |
dc.subject.other | Epidermal Growth Factor | en_US |
dc.subject.other | Insulin | en_US |
dc.subject.other | Rat Mammary Tumors | en_US |
dc.title | Multiple growth factor independence in rat mammary carcinoma cells | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbsecondlevel | Ophthalmology | en_US |
dc.subject.hlbsecondlevel | Otolaryngology | en_US |
dc.subject.hlbsecondlevel | Obstetrics and Gynecology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Radiation Oncology, The University of Michigan Medical School, 1331 E. Ann St., 48109, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationum | Department of Radiation Oncology, The University of Michigan Medical School, 1331 E. Ann St., 48109, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 1912610 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/44197/1/10549_2005_Article_BF01980969.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1007/BF01980969 | en_US |
dc.identifier.source | Breast Cancer Research and Treatment | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.